Human immunodeficiency virus type 1
| Catalog # |
Product Name |
Size | Storage | Bio Cat. | Status |
|---|---|---|---|---|---|
| 13-108-100 | HIV-1 anti-gp120 env | 100 µg | -20˚C | ||
| 13-105-100 | HIV-1 anti-gp120 env (aa 307-320) | 100 µg | -20˚C | ||
| 13-104-100 | HIV-1 anti-gp41 env | 100 µg | -20˚C | ||
| 13-103-100 | HIV-1 anti-p17 gag | 100 µg | -20˚C | ||
| 13-102-100 | HIV-1 anti-p24 gag | 100 µg | -20˚C | ||
| 13-137-100 | HIV-1 anti-p66/51 pol | 100 µg | -20˚C | ||
| 10-177-000 | HIV-1 Ba-L Strain Direct Pelleted Virus (500X) | 1.0 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-124-000 | HIV-1 IIIB Strain Direct Pelleted Virus (1000X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-124-PNK | HIV-1 IIIB Strain Direct Pelleted Virus (100X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 14-102-050 | HIV-1 IIIB Strain gp120 Purified Native Glycoprotein | 50 µg | -70˚C | ||
| 14-103-050 | HIV-1 IIIB Strain gp160 env Purified Native Glycoprotein | 50 µg | -70˚C | ||
| 14-127-050 | HIV-1 IIIB Strain gp160 Recombinant Viral Protein | 50 µg | -70˚C | ||
| 10-530-001 | HIV-1 IIIB Strain Inactivated Cell Extract | 1.0 mL | -70˚C | ||
| 10-530-025 | HIV-1 IIIB Strain Inactivated Cell Extract | 25 mL | -70˚C | ||
| 08-707-000 | HIV-1 IIIB Strain Infected Cell DNA | 100 µL | -20˚C | ||
| 14-108-050 | HIV-1 IIIB Strain nef Recombinant Viral Protein | 50 µg | -70˚C | ||
| 14-101-050 | HIV-1 IIIB Strain p24 gag Purified Native Protein | 50 µg | -70˚C | ||
| 14-126-050 | HIV-1 IIIB Strain p24 Recombinant Viral Protein | 50 µg | -70˚C | ||
| 14-128-050 | HIV-1 IIIB Strain p66 (Reverse Transcriptase) Recombinant Viral Protein | 50 µg | -70˚C | ||
| 10-119-000 | HIV-1 IIIB Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-118-000 | HIV-1 IIIB Strain Purified Virus | 1 mg | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 13-204-000 | HIV-1 IIIB Strain Rabbit anti-gp120 Polyclonal | 0.5 mL | -20˚C | ||
| 13-203-000 | HIV-1 IIIB Strain Rabbit anti-p24 Polyclonal | 0.5 mL | -20˚C | ||
| 14-129-050 | HIV-1 MN Strain gp120 Recombinant Viral Protein | 50 µg | -70˚C | ||
| 14-109-050 | HIV-1 pHXB2 Strain gp41 Recombinant Viral Protein | 50 µg | -70˚C |
|
|
| 10-228-000 | HIV-1 pHXB2D Strain Direct Pelleted Virus (1000X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-226-000 | HIV-1 pHXB2D Strain Direct Pelleted Virus (500X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |


